Latest News

Intravenously administered ketamine shown to reduce symptoms of chronic post-traumatic stress disorder

For the first time, evidence that a single dose of IV-administered ketamine was associated with the rapid reduction of symptoms of post-traumatic stress disorder in patients with chronic PTSD was demonstrated in a proof-of-concept, randomized, double blind crossover study. These findings could be the first step toward developing new interventions for PTSD.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • New theoretical framework for future studies of resilience

  • Stress during pregnancy related to infant gut microbiota

  • Connection between childhood adversity, psychiatric disorders seen at cellular level

  • How the brain recognizes danger: New discovery

  • A paradox revealed: Cues associated with infant abuse may help reduce stress in the adult brain

  • Sexual objectification increases women's fear of crime

  • United States: Mental health care lacking in state, federal prisons

  • Study identifies two genes that boost risk for post-traumatic stress disorder

  • Could gut microbes help treat brain disorders? Mounting research tightens their connection with the brain

  • Physical recovery in critically ill patients can predict remission of anxiety, PTSD symptoms

  •